AR057526A1 - Metodos para la produccion de composiciones oftalmicas oxidativamente estables - Google Patents
Metodos para la produccion de composiciones oftalmicas oxidativamente establesInfo
- Publication number
- AR057526A1 AR057526A1 ARP060104336A ARP060104336A AR057526A1 AR 057526 A1 AR057526 A1 AR 057526A1 AR P060104336 A ARP060104336 A AR P060104336A AR P060104336 A ARP060104336 A AR P060104336A AR 057526 A1 AR057526 A1 AR 057526A1
- Authority
- AR
- Argentina
- Prior art keywords
- production
- methods
- ophthalmic compositions
- oxidatively stable
- stable ophthalmic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D19/00—Degasification of liquids
- B01D19/0005—Degasification of liquids with one or more auxiliary substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D19/00—Degasification of liquids
- B01D19/0036—Flash degasification
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D19/00—Degasification of liquids
- B01D19/0073—Degasification of liquids by a method not covered by groups B01D19/0005 - B01D19/0042
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D19/00—Degasification of liquids
- B01D19/0073—Degasification of liquids by a method not covered by groups B01D19/0005 - B01D19/0042
- B01D19/0078—Degasification of liquids by a method not covered by groups B01D19/0005 - B01D19/0042 by vibration
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D7/00—Sublimation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D7/00—Sublimation
- B01D7/02—Crystallisation directly from the vapour phase
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente se relaciona con un proceso para mejorar la estabilidad de una solucion compatible para uso oftalmologico que comprende por lo menos un compuesto oftálmico oxidativamente inestable. Reivindicacion 1: Un proceso que comprende la remocion de por lo menos 80% del oxígeno de una solucion compatible para uso oftalmologico que comprende por lo menos un compuesto oftálmico oxidativamente inestable.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/241,313 US20070077303A1 (en) | 2005-09-30 | 2005-09-30 | Methods for providing oxidatively stable ophthalmic compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
AR057526A1 true AR057526A1 (es) | 2007-12-05 |
Family
ID=37619526
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP060104336A AR057526A1 (es) | 2005-09-30 | 2006-10-02 | Metodos para la produccion de composiciones oftalmicas oxidativamente estables |
Country Status (11)
Country | Link |
---|---|
US (2) | US20070077303A1 (es) |
EP (1) | EP1769834A3 (es) |
JP (1) | JP2007099768A (es) |
KR (1) | KR20070037415A (es) |
CN (1) | CN1939278A (es) |
AR (1) | AR057526A1 (es) |
AU (1) | AU2006225174B2 (es) |
BR (1) | BRPI0604723A (es) |
CA (1) | CA2561676A1 (es) |
SG (1) | SG131101A1 (es) |
TW (1) | TW200730468A (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0709549A2 (pt) * | 2006-03-17 | 2011-07-19 | Johnson & Johnson Vision Care | métodos para estabilizar composições instáveis oxidativamente |
ES2752823T3 (es) | 2006-03-31 | 2020-04-06 | Vistakon Pharmaceuticals Llc | Tratamiento de alergias oculares |
WO2008151019A1 (en) * | 2007-05-30 | 2008-12-11 | University Of Florida Research Foundation, Inc. | Extended release of bioactive molecules from silicone hydrogels |
US8614210B2 (en) * | 2009-12-03 | 2013-12-24 | Lupin Limited | Process for preparing pharmaceutical ophthalmic compositions |
US9244203B2 (en) * | 2011-08-31 | 2016-01-26 | Johnson & Johnson Vision Care, Inc. | Liquid meniscus lens with improved saline formulation |
KR101703980B1 (ko) * | 2013-12-30 | 2017-02-08 | 주식회사 삼양바이오팜 | 항산화제를 함유하지 않는 약학 조성물 및 그의 제조방법 |
KR101919436B1 (ko) * | 2015-05-28 | 2018-11-16 | 주식회사 삼양바이오팜 | 안정화된 약학 조성물 및 그의 제조방법 |
GR1008942B (el) * | 2015-10-14 | 2017-02-06 | ΙΟΥΛΙΑ ΚΑΙ ΕΙΡΗΝΗ ΤΣΕΤΗ ΦΑΡΜΑΚΕΥΤΙΚΑ ΕΡΓΑΣΤΗΡΙΑ ΑΒΕΕ με δ.τ. "INTERMED ΑΒΕΕ" | Μεθοδος παραγωγης σταθερου υδατικου διαλυματος λυσινικης ιμπουπροφαινης για ενδοκολπικη χρηση |
CN108686252B (zh) * | 2018-06-11 | 2021-05-18 | 深圳英凡妮生物科技有限公司 | 一种以壳聚糖-泊洛沙姆为基质的纳米银抗菌敷料及其制备方法和应用 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3639576A (en) * | 1968-06-19 | 1972-02-01 | Barnes Hind Pharm Inc | Resterilizing contact lens solution |
BE901885A (fr) * | 1985-03-06 | 1985-07-01 | Bruschettini Srl | Composition pharmaceutique sous forme de lotion ophtalmique et son procede de preparation. |
US4931225A (en) * | 1987-12-30 | 1990-06-05 | Union Carbide Industrial Gases Technology Corporation | Method and apparatus for dispersing a gas into a liquid |
US4853088A (en) * | 1988-04-12 | 1989-08-01 | Marathon Oil Company | Solar enhanced separation of volatile components from a liquid |
IL101850A (en) * | 1991-06-13 | 1996-01-31 | Janssen Pharmaceutica Nv | History 11-) 4-Pipridinyl (-Imidazo] B-1, 2 [] 3 [Benzazepine, their preparation and pharmaceutical preparations containing them |
IT1258781B (it) * | 1992-01-16 | 1996-02-29 | Zambon Spa | Composizione farmaceutica oftalmica contenente n-acetilcisteina e polivinilalcol |
JPH07286027A (ja) * | 1994-04-19 | 1995-10-31 | Hoya Corp | 眼装着用レンズ材料及びそれを用いた眼装着用レンズ |
US5597519A (en) * | 1994-06-10 | 1997-01-28 | Johnson & Johnson Vision Products, Inc. | Ultraviolet cycling oven for polymerization of contact lenses |
US5922249A (en) * | 1995-12-08 | 1999-07-13 | Novartis Ag | Ophthalmic lens production process |
JP3689900B2 (ja) * | 1998-08-19 | 2005-08-31 | ニプロ株式会社 | 医療用成形品 |
FR2809619B1 (fr) * | 2000-06-06 | 2004-09-24 | Pharmatop | Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention |
US20020037897A1 (en) * | 2000-08-07 | 2002-03-28 | 3-Dimensional Pharmaceuticals, Inc. | Tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidines as integrin antagonists |
AR034372A1 (es) * | 2001-06-08 | 2004-02-18 | Novartis Ag | Composiciones farmaceuticas |
AU2002345015A1 (en) * | 2001-06-08 | 2002-12-23 | Novartis Pharma Gmbh | Ophthalmic once-a-day composition |
US20060100408A1 (en) * | 2002-03-11 | 2006-05-11 | Powell P M | Method for forming contact lenses comprising therapeutic agents |
DE20217473U1 (de) * | 2002-11-11 | 2003-03-27 | Analysen Service Gmbh Umwelt U | Entgasungsmodul für Fluidproben |
JP2005124809A (ja) * | 2003-10-23 | 2005-05-19 | Sanyo Chem Ind Ltd | 医療用接着剤 |
FR2894154B1 (fr) * | 2005-12-06 | 2008-03-14 | Pharmatop Scr | Nouveau procede de stabilisation de substances minerales ou organiques sensibles a l'oxydation. |
-
2005
- 2005-09-30 US US11/241,313 patent/US20070077303A1/en not_active Abandoned
-
2006
- 2006-09-29 KR KR1020060096143A patent/KR20070037415A/ko not_active Application Discontinuation
- 2006-09-29 CA CA002561676A patent/CA2561676A1/en not_active Abandoned
- 2006-09-29 BR BRPI0604723-8A patent/BRPI0604723A/pt not_active IP Right Cessation
- 2006-09-29 TW TW095136125A patent/TW200730468A/zh unknown
- 2006-09-29 SG SG200606814-2A patent/SG131101A1/en unknown
- 2006-09-29 EP EP06255060A patent/EP1769834A3/en not_active Withdrawn
- 2006-09-29 JP JP2006267359A patent/JP2007099768A/ja active Pending
- 2006-09-29 AU AU2006225174A patent/AU2006225174B2/en not_active Ceased
- 2006-09-30 CN CNA2006101447395A patent/CN1939278A/zh active Pending
- 2006-10-02 AR ARP060104336A patent/AR057526A1/es not_active Application Discontinuation
-
2011
- 2011-04-27 US US13/095,150 patent/US20110201596A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
KR20070037415A (ko) | 2007-04-04 |
US20070077303A1 (en) | 2007-04-05 |
BRPI0604723A (pt) | 2007-08-28 |
CA2561676A1 (en) | 2007-03-30 |
CN1939278A (zh) | 2007-04-04 |
EP1769834A3 (en) | 2009-10-07 |
AU2006225174A1 (en) | 2007-04-19 |
AU2006225174B2 (en) | 2012-07-05 |
EP1769834A2 (en) | 2007-04-04 |
US20110201596A1 (en) | 2011-08-18 |
TW200730468A (en) | 2007-08-16 |
SG131101A1 (en) | 2007-04-26 |
JP2007099768A (ja) | 2007-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR057526A1 (es) | Metodos para la produccion de composiciones oftalmicas oxidativamente estables | |
MA33275B1 (fr) | Inhibiteurs de la replication du virus de l'immunodeficience humaine | |
ECSP078060A (es) | 2,4-diamino-pirimidinas como inhibidores de aurora | |
MY155317A (en) | Benzene sulfonamide thiazole and oxazole compounds | |
NI200700064A (es) | Nuevas composiciones farmacéuticas que comprenden ácido 4-(4-(3-(4-cloro-3- trifluorometil-fenil)- ureido)-3-fluoro-fenoxi)-piridin-2-carboxílico para el tratamiento de trastornos hiperproliferativos. | |
CR7995A (es) | Nueva difenilazetidinona con caracteristicas fisiologicas mejoradas correspondiente metodo de produccion , medicamentos que lo contienen y uso de los mismos | |
AR053162A1 (es) | Compuesto 5 - oxo - pirrolidin sustituido, composicion farmaceutica que lo comprende y su uso para preparar un medicamento para el tratamiento del glaucoma. | |
UY32072A (es) | Tienopirimidinas para composiciones farmacéuticas | |
UY29927A1 (es) | Derivados sustituidos de la 5-fenil-2-tioxo-imidazolin-4-ona y de la 5-fenil-2-amino-imidazolidin-4-ona y sus sales, composiciones y aplicaciones | |
UY32259A (es) | Nuevos compuestos de hidroxiareno, preparados farmaceuticos que los contienen y aplicaciones | |
IS2533B (is) | (S)-2-N-própýlamínó-5-hýdroxýetralín sem D3-gerandefni | |
PA8671301A1 (es) | Pirrolopiridinas sustituidas, composiciones que las contienen, proceso de fabricación y utilización | |
GT200600086A (es) | Forma cristalina de gamma-d del clorhidrato de ivabradina, su procedimiento de preparación y composiciones farmacéuticas que la contienen | |
DE502005008057D1 (de) | Substituierte cyclopenten-verbindungen | |
CR10479A (es) | Modulares bencimidazolicos de vr1 | |
MA35749B1 (fr) | Dérivés nucléosidiques 4'-azido, 3'-fluoro substitués en tant qu'inhibiteurs de la réplication de l'arn du vhc | |
ECSP10010310A (es) | Nuevos compuestos y composiciones y métodos de uso | |
UY27516A1 (es) | Bencimidazoles | |
ECSP088099A (es) | Nuevos derivados de la 2-azetidinona para el tratamiento de enfermedades hiperlipidémicas | |
BR112013020767A2 (pt) | composições compreendendo ácido peróxi alfa-cetocarboxílico e métodos para a produção e o uso do mesmo | |
MX2010003224A (es) | Derivados de biaril sulfonamida. | |
UY29648A1 (es) | Derivados de piridopirimidina, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones | |
AR056558A1 (es) | Metodos para estabilizar composiciones oftalmicas | |
BRPI0607258A2 (pt) | uso, composto, bem como formulações farmacêuticas | |
EA200602049A1 (ru) | Пролекарства стероидов с андрогенным действием |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |